Biohaven Pharmaceutical

Biohaven Pharmaceutical — Acquisitions

Every M&A deal made by Biohaven Pharmaceutical, sorted by date.

📍 New Haven Total deals 2 Total value $120.0M View company profile →
2
Total deals
$120.0M
Total value
$60.0M
Avg deal
$100.0M
Largest
Acquisition activity by year
Deals announced per year
21 22
# Acquired Date Type Status Price
1
C
Channel Biosciences
Channel Biosciences offers the Kv7 Ion Channel Platform for the Treatment of Epi…
2022-02-25 Acquisition Complete $100.0M Deal →
2
Kleo
Kleo is developing two types of small molecules to treat cancer, infectious dise…
2021-01-07 Acquisition Complete $20.0M Deal →